From a New York Times online article:
At Dr. Soong’s hospital, withholding the results of urine cultures, unless doctors actually called the microbiology lab to request them, reduced prescriptions for asymptomatic bacteriuria to 12 percent from 48 percent of non-catheterized patients, with no loss of safety.
“The extra step of having the clinician call eliminated a lot of frivolous testing,” Dr. Soong said.
In patients who have none of the typical symptoms of a urinary tract infection — no painful or frequent urination, no blood in the urine, no fever or lower abdominal tenderness — lab results detecting bacteria in the urine don’t indicate infection and thus shouldn’t trigger treatment.
Older people, and nursing home residents in particular, often have urinary systems colonized by bacteria; they will have a positive urine test almost every time, but they’re not sick.
To read more: https://www.nytimes.com/2019/10/14/health/urine-tests-elderly.html
Most Americans probably aren’t aware of the decline in the number of individuals training to become transplant physicians and how it will affect the future of medicine. Neither are the 2020 presidential hopefuls, all of whom have policies they believe best provide health care coverage for Americans without acknowledging or calling attention to the fact that soon there may not be enough doctors to do the work once more people are insured. We need a plan for that.
Our 3D deep-learning system performed well in both primary and external validations, suggesting that it could potentially be used for automated detection of glaucomatous optic neuropathy based on SDOCT volumes. Screening with the deep-learning system is much faster than conventional glaucoma screening methods (ie, by experienced specialists), can be done automatically, and does not require a large number of trained personnel on site. Further prospective studies are warranted to estimate the incremental cost-effectiveness of incorporating this artificial intelligence-based model for screening for glaucoma, both in the general population and among at-risk people.
But greater use of biosimilars could create significantly more savings. If biosimilars obtained a 75 percent market share, less than the share of these medicines in many European Union nations, the resulting annual savings for the U.S. healthcare system could be nearly $7 billion, based on Winegarden’s analysis.
The irony is 
In summary, dietary fructose, but not glucose, supplementation of HFD impairs mitochondrial size, function, and protein acetylation, resulting in decreased fatty acid oxidation and development of metabolic dysregulation.
EIR Healthcare collaborates with each hospital to customize the optimal space. Through our technology and design, doctors, nurses and any healthcare professional interacting with patients in a MedModular room are equipped to provide nothing short of excellence within every interaction. EIR Healthcare was presented with a 2018 iF Design Award for our “Hospital of the Future” professional concept.
Kaia’s iOS and Android apps were developed with the help of physiotherapists, pain management physicians, orthopedic surgeons, and clinical psychologists, the company claims, and are registered as Class 1 medical devices with the Food and Drug Administration. They serve up video clips covering basic back and COPD pain information and step-by-step physiotherapy exercises, in addition to psychological strategies, such as mindfulness and muscle relaxation.
Boomers Daily 